Neuromyelitis Optica Spectrum Disorder: Novel Therapeutic Landscape and Impact on Treatment Paradigms

Release Date: 7/28/2022Expiration Date: 7/27/2023 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. There is no non-commercial support for this activity. Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will …

The Changing Face of Multiple Sclerosis: Addressing the Demographic Shift Towards Elderly Patients

Release Date: 7/18/2022Expiration Date: 7/17/2023 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from EMD Serono, Inc. There is no non-commercial support for this activity. Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be …

MS Forum® VIII: Advancing MS Care in the Pandemic Era

Three-Part CE Webinar Series Register for each CME/CNE webinar below. Attend all 3 to earn up to 6.0 CME/CNE credits! Series Overview Multiple sclerosis (MS) is a chronic, often disabling disease that attacks the central nervous system. The management of patients with MS is highly complex, and the development of disease-modifying therapies (DMTs) has dramatically …

IJMSC: Nursing Interventions Focused on Self-efficacy for Patients With Multiple Sclerosis in Rehabilitation: A Systematic Review

Release Date: July 1, 2022 Valid for Credit through: July 1, 2023 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is nursing professionals, advanced practice clinicians, physicians, rehabilitation professionals, mental health professionals, social workers, and other health care providers involved in the …

Optimizing Multiple Sclerosis Care in the General Neurology Setting Interactivity Module

Release Date: July 7, 2022 Expiration Date: July 7, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants from Bristol Myers Squibb and Genentech. Target Audience This activity is designed to meet the educational needs of general neurology …

IJMSC: The Impact of COVID-19 on the Lives of People With Multiple Sclerosis: 1 Year Into the Pandemic

Release Date: May 1, 2022 Valid for Credit through: May 1, 2023 Activity Available Online: To access the article, post-test, and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, mental health professionals, social workers, and other health care providers involved in the management …

IJMSC: Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population

Release Date: April 1, 2022 Valid for Credit through: April 1, 2023 Activity Available Online: To access the article, post-test, and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, pharmacists, and other health care providers involved in the management of patients with multiple …

Optimizing Multiple Sclerosis Care in the General Neurology Setting

Release Date: April 19, 2022Expiration Date: April 19, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants fromBristol Myers Squibb and Genentech. Target Audience General neurology physicians, PAs, nurse practitioners, nurses, and other healthcare professionals involved in the …

Medical Crossfire®: Sequencing of Disease-Modifying Therapies—Optimizing Outcomes in Patients With Multiple Sclerosis

Released On: January 6, 2022 Expires On: January 6, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Physicians’ Education Resource®, LLC. This activity is supported by an independent educational grant fromBiogen. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ All other healthcare professionals completing this course …

MedEd Talks Neurology Podcasts

The rapidly expanding range of disease modifying therapies (DMTs) has changed the clinical approach to the management of patients with multiple sclerosis (MS). The emergence of numerous therapeutic options combined with the longevity and variable disease course of MS has led to the need to consider additional factors, such as safety, convenience, care during COVID-19, …